Skip to content
Biodatica
Start free

Investigator

Hector Hugo Garcia

UNIVERSIDAD PERUANA CAYETANO HEREDIA · funded by NIAID, FIC

Companies
2

Resolved onto their grants.

Grants
3

Federal awards on file.

Non-dilutive funding
$1.8M

Summed across those awards.

First award
Jul 1, 1999

Latest Sep 1, 2023.

Companies from this work

Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.

Grant record

Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.

  1. U01

    A multicenter, randomized controlled trial of single and multiple dose regimes of oxfendazole for mild (one or two lesions) parenchymal brain cysticercosis

    $942k

    Sep 1, 2023NIAIDUNIVERSIDAD PERUANA CAYETANO HEREDIANIH RePORTER · 11101260 (opens the source filing in a new tab)

  2. U01

    A Non-Inferiority Randomized Single Blind Controlled Trial Comparing One and Two Dose Regimes of Oxfendazole versus a Two Dose Regime of Triclabendazole to Treat Chronic Fascioliasis

    $561k

    Aug 17, 2023NIAIDUNIVERSIDAD PERUANA CAYETANO HEREDIANIH RePORTER · 11141568 (opens the source filing in a new tab)

  3. D43

    Training in Infectious Diseases in Peru - Time for Implementation Research

    $290k

    Jul 1, 1999FICUNIVERSIDAD PERUANA CAYETANO HEREDIANIH RePORTER · 11042152 (opens the source filing in a new tab)

This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources